Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-26 @ 3:20 PM
NCT ID:
NCT07479602
Eligibility Criteria:
Inclusion Criteria:
* Aged 3-7 years old.
* Scheduled to undergo adenoidectomy and/or tonsillectomy under general anesthesia.
* Provides written informed consent by the guardian.
Exclusion Criteria:
* Unsuitable for intranasal administration due to nasal diseases (such as rhinitis, nasal polyps, or any condition causing nasal congestion).
* Clearly diagnosed cardiovascular and respiratory diseases.
* Communication barriers due to delayed neurological development or visual or hearing impairments.
* Traumatic brain injury or neurosurgery.
* Abnormal liver and kidney function (biomarkers higher than twice of the upper normal limits).
* Amercian Society of Anesthesiologists classification ≥ III.
* Body mass index higher than the 95th percentile of the age- and sex-standardized references.
* Allergic to dexmedetomidine and/or esketamine.
* Any other conditions that are deemed unsuitable for study participation.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
3 Years
Maximum Age:
7 Years
Study:
NCT07479602
Study Brief:
Protocol Section:
NCT07479602